MedPath

Tropisetron

Generic Name
Tropisetron
Drug Type
Small Molecule
Chemical Formula
C17H20N2O2
CAS Number
89565-68-4
Unique Ingredient Identifier
6I819NIK1W
Background

Tropisetron is an indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, tropisetron competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.

Tropisetron appears to be well tolerated with the most frequently reported adverse effect being headache. Extrapyramidal side effects are rare upon using tropisetron.

Indication

For the prevention of nausea and vomiting induced by cytotoxic therapy and postoperative.

Associated Conditions
Chemotherapy-Induced Nausea and Vomiting

The Central Analgesic Effects of Paracetamol on Serotonergic Pathways

Not Applicable
Completed
Conditions
Analgesia
Interventions
First Posted Date
2009-09-02
Last Posted Date
2013-01-29
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
16
Registration Number
NCT00970450
Locations
🇨🇭

University Hospital of Basel, Basel, Switzerland

Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron

Phase 2
Completed
Conditions
Pain
Chronic Disease
Interventions
First Posted Date
2009-04-29
Last Posted Date
2011-03-24
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
30
Registration Number
NCT00889499
Locations
🇨🇭

Dep. of Anesthesiology and Pain Therapy, Bern University Hospital, Inselspital, Bern, Switzerland

Clinical Confirmation of a Pharmacodynamic Interaction Between Tropisetron and Paracetamol

Phase 4
Completed
Conditions
Pain
First Posted Date
2007-06-15
Last Posted Date
2010-03-29
Lead Sponsor
University Hospital, Clermont-Ferrand
Target Recruit Count
40
Registration Number
NCT00487110
Locations
🇫🇷

CHU, Clermont-Ferrand, France

Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

Phase 3
Completed
Conditions
Smoking Cessation
Schizophrenia
Interventions
First Posted Date
2007-02-14
Last Posted Date
2017-03-15
Lead Sponsor
Baylor College of Medicine
Target Recruit Count
179
Registration Number
NCT00435370
Locations
🇨🇳

Beijing Hui-Long Guan Hospital, Beijing, China

🇺🇸

Baylor College of Medicine - Michael E. DeBakey VA Medical Center, Houston, Texas, United States

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Phase 2
Completed
Conditions
Nausea and Vomiting
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-03-23
Last Posted Date
2015-10-15
Lead Sponsor
Gary Morrow
Target Recruit Count
700
Registration Number
NCT00003817
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

🇺🇸

University of Rochester Cancer Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath